TY - JOUR T1 - Using discrete Ricci curvatures to infer COVID-19 epidemic network fragility and systemic risk JF - medRxiv DO - 10.1101/2020.04.01.20047225 SP - 2020.04.01.20047225 AU - Danillo Barros de Souza AU - Jonatas T. S. da Cunha AU - Everlon Figueirôa dos Santos AU - Jailson B. Correia AU - Hernande P. da Silva AU - José Luiz de Lima Filho AU - Jones Albuquerque AU - Fernando A. N. Santos Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/07/2020.04.01.20047225.abstract N2 - The damage of the novel Coronavirus disease (COVID-19) is reaching unprecedented scales. There are numerous classical epidemiology models trying to quantify epidemiology metrics. Usually, to forecast epidemics, classical approaches need parameter estimations, such as the contagion rate or the basic reproduction number. Here, we propose a data-driven, parameter-free, geometric approach to access the emergence of a pandemic state by studying the Forman-Ricci and Ollivier-Ricci network curvatures. Discrete Ollivier-Ricci curvature has been used successfully to forecast risk in financial networks and we suggest that those results can provide analogous results for COVID-19 epidemic time-series. We first compute both curvatures in a toy-model of epidemic time-series with delays, which allows us to create epidemic networks. By doing so, we are able to verify that the Ollivier-Ricci and Forman-Ricci curvatures can be a parameter-free estimate for identifying a pandemic state in the simulated epidemic. On this basis, we then compute both Forman-Ricci and Ollivier-Ricci curvatures for real epidemic networks built from COVID-19 epidemic time-series available at the World Health Organization (WHO). Both curvatures allow us to detect early warning signs of the emergence of the pandemic. The advantage of our method lies in providing an early geometrical data marker for the pandemic state, regardless of parameter estimation and stochastic modelling. This work opens the possibility of using discrete geometry to study epidemic networks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was partially funded by INES 2.0, FACEPE grants PRONEX APQ-0602-1.05/14, APQ 0388-1.03/14 and APQ-0399-1.03/17, CAPES grant 88887.136410/2017-00, and CNPq grant 465614/2014-0Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is freely available at the World Health Organization (WHO) ER -